Dose-dependent effects of oral acyclovir in the incubation period of varicella

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 12, 1996, Pages 1418-1421

  Suga, S ^a   Yoshikawa, T ^a   Yazaki, T ^a   Ozaki, T ^b   Asano, Y ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acyclovir; incubation period; oral administration; varicella; varicella zoster virus

Indexed keywords

ACICLOVIR;

ANTIBODY TITER; ARTICLE; CHILD; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; INCUBATION TIME; INFANT; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 0029796001     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb13945.x     Document Type: Article

References (15)

1. Balfour HH, Kelly JM, Suarez CS, Heussener RC, England JA, Crane DD, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr 1990; 116: 633-9
2. Dunkle LM, Arvin AM, Whitley RJ, Rotbart HA, Feder HM Jr, Feldman S, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325: 1539-44
3. Balfour HH, Rotbart HA, Feldman S, Dunkle LM, Feder HM Jr, Prober CG, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. J Pediatr 1992; 120: 627-33
4. Feder HM. Treatment of adult chickenpox with oral acyclovir. Arch Intern Med 1990; 150: 2061-5
5. Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield EC III. Treatment of adult varicella with oral acyclovir. Ann Intern Med 1992; 117: 358-63
6. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 1993; 92: 219-22
7. Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 1993; 69: 639-43
8. Kallander CFR, Gronowitz JS, Olding-Stenkvist E. Varicella zoster virus deoxythymidine kinase is present in serum before the onset of varicella. Scand J Infect Dis 1989; 21: 255-7
9. Asano Y, Itakura N, Hiroishi Y, Hirose S, Ozaki T, Kuno K, et al. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 1985; 152: 863-8
10. Asano Y, Itakura N, Kajita Y, Suga S, Yoshikawa T, Yazaki T, et al. Severity of viremia and clinical findings in children with varicella. J Infect Dis 1990; 161: 1095-8
11. Asano Y, Yoshikawa T, Urisu A, Yazaki T, Mizoguchi Y, Kurata T. Varicella-zoster virus replication site in internal organs of an otherwise healthy child with varicella and sudden death. Acta Peadiatr Jpn 1993; 35: 348-51
12. Asano Y, Albrecht P, Vujcic LK, Quinnan GV Jr, Kawakami K, Takahashi M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics 1983; 72: 291-4
13. White CB, Hawley WZ, Harford DJ. The pediatric resident susceptible to varicella: providing immunity through postexposure prophylaxis with oral acyclovir. Pediatr Infect Dis J 1994; 13: 743-5
14. Asano Y, Nagai T, Miyata T, Yazaki T, Ito S, Yamanishi K, et al. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Pediatrics 1985; 75 :667-71
15. Huang YC, Lin TY, Chiu CH. Acyclovir prophylaxis of varicella after household exposure. Pediatr Infect Dis J 1995; 14: 152-4